Related Experiment Video
Updated: May 13, 2026

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
Published on: November 12, 2015
Molecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin E
Pei-Hsin Cheng1, Xiao-Mei Rao, Kelly M McMasters
1Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Abstract:
Adenoviruses (Ads) with deletion of E1b55K preferentially replicate in cancer cells and have been used in cancer therapies. We have previously shown that Ad E1B55K protein is involved in induction of cyclin E for Ad replication, but this E1B55K function is not required in cancer cells in which deregulation of cyclin E is frequently observed. In this study, we investigated the interaction of cyclin E and CDK2 in Ad-infected cells. Ad infection significantly increased the large form of cyclin E (cyclin EL), promoted cyclin E/CDK2 complex formation and increased CDK2 phosphorylation at the T160 site. Activated CDK2 caused pRb phosphorylation at the S612 site. Repression of CDK2 activity with the chemical inhibitor roscovitine or with specific small interfering RNAs significantly decreased pRb phosphorylation, with concomitant repression of viral replication. Our results suggest that Ad-induced cyclin E activates CDK2 that targets the transcriptional repressor pRb to generate a cellular environment for viral productive replication. This study reveals a new molecular basis for oncolytic replication of E1b-deleted Ads and will aid in the development of new strategies for Ad oncolytic virotherapies.
Insights
Adenoviruses lacking E1b55K replicate in cancer cells by activating cyclin E/CDK2. This complex phosphorylates pRb, promoting viral replication and aiding oncolytic virotherapy development.
Area of Science:
- Oncolytic virotherapy
- Molecular biology
- Cancer research
Background:
- Adenoviruses (Ads) with E1b55K deletion show oncolytic potential, preferentially replicating in cancer cells.
- Previous work linked Ad E1B55K protein to cyclin E induction for viral replication, a function less critical in cancer cells with deregulated cyclin E.
Purpose of the Study:
- To investigate the interaction between cyclin E and CDK2 in Ad-infected cells.
- To elucidate the role of the cyclin E/CDK2 complex in Ad replication within cancer cells.
Main Methods:
- Studied Ad-infected cells to analyze cyclin E forms and CDK2 activity.
- Utilized roscovitine and small interfering RNAs to inhibit CDK2 activity.
- Assessed pRb phosphorylation and viral replication rates.
Main Results:
- Ad infection increased large cyclin E (cyclin EL) and cyclin E/CDK2 complex formation.
- CDK2 phosphorylation at T160 and subsequent pRb phosphorylation at S612 were observed.
- CDK2 inhibition significantly reduced pRb phosphorylation and viral replication.
Conclusions:
- Ad-induced cyclin E activates CDK2, which phosphorylates pRb, creating a favorable cellular environment for viral replication.
- This mechanism provides a molecular basis for the oncolytic replication of E1b-deleted Ads.
- Findings support the development of novel Ad-based oncolytic virotherapies.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

